TFF Pharmaceuticals Receives Notice of Intention to Grant European Patent for Its Thin Film Freezing Process, Providing IP Protection in Europe until 2028

AUSTIN, Texas–(BUSINESS WIRE)–TFF Pharmaceuticals, Inc., an early-stage biopharmaceutical company focused on developing and commercializing new inhalation drug products for the treatment of chronic respiratory diseases and lung conditions, today announced having received a European Patent Office (EPO) Notice of Intent to Grant Patent Application No. 08771657.7, “Formation of…Read More

Contact Us

Let us know if you would like more information about TFF
  • This field is for validation purposes and should be left unchanged.